| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CITIUS ONCOLOGY, INC. | Chief Medical Officer | Stock Option (Right to Buy) | 1,400,000 | $2,926,000 | $2.09 | 19 Sep 2025 | Direct |
| CITIUS ONCOLOGY, INC. | Chief Medical Officer | Common Stock | 825,000 | $1,097,250 | $1.33 | 19 Sep 2025 | Direct |
| Citius Pharmaceuticals, Inc. | Chief Medical Officer | Stock Option (Right to Purchase Common Stock) | 300,000 | 07 Nov 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CTOR | CITIUS ONCOLOGY, INC. | 19 Sep 2025 | 1 | $0 | 4/A | Chief Medical Officer | 22 Dec 2025, 16:10 |
| CTOR | CITIUS ONCOLOGY, INC. | 19 Sep 2025 | 1 | $0 | 4/A | Chief Medical Officer | 01 Dec 2025, 16:10 |
| CTOR | CITIUS ONCOLOGY, INC. | 12 Dec 2024 | 1 | $0 | 4 | Chief Medical Officer | 16 Dec 2024, 16:05 |
| CTXR | Citius Pharmaceuticals, Inc. | 07 Nov 2024 | 1 | $0 | 4 | Chief Medical Officer | 12 Nov 2024, 17:00 |
| CTOR | CITIUS ONCOLOGY, INC. | 12 Aug 2024 | 1 | $0 | 4/A | Chief Medical Officer | 30 Aug 2024, 16:05 |
| CTOR | CITIUS ONCOLOGY, INC. | 12 Aug 2024 | 0 | $0 | 3 | Chief Medical Officer | 14 Aug 2024, 18:22 |
| CTXR | Citius Pharmaceuticals, Inc. | 10 Oct 2023 | 1 | $0 | 4 | Chief Medical Officer | 12 Oct 2023, 16:15 |
| CTXR | Citius Pharmaceuticals, Inc. | 04 Oct 2022 | 1 | $0 | 4 | Chief Medical Officer | 06 Oct 2022, 16:05 |
| CTXR | Citius Pharmaceuticals, Inc. | 11 Oct 2021 | 1 | $0 | 4 | Chief Medical Officer | 13 Oct 2021, 17:25 |